Abstract:Objective:To investigate the effect of infliximab (IFX) on neurological function in mice after traumatic brain injury (TBI) and the role of nuclear factor-κB (NF-κB)/inducible nitric oxide lyase (iNOS) signaling in it.Methods:Seventy-two healthy adult male C57BL/6 mice were randomly divided into sham-operated group, TBI group, and TBI+IFX group ( n=24). The mouse TBI models were established by controlled cortical impact method. IFX (dissolved in normal saline at a concentration of 2.5 mg/mL and a dose of 10 μg/g) was administered intraperitoneally into the mice of TBI+IFX group 30 min after modeling once daily for 3 d; mice in the sham-operated group and TBI group were given the same amount of saline intraperitoneally at the same time points for 3 d. Neurological deficits (Garcia scores) were assessed one, 3 and 7 d after modeling; blood-brain barrier permeability was detected by Evans blue staining, and brain tissue water content was measured by dry and wet weight method; Nissl staining was used to detect the percentage of injured neurons in brain tissues; the percentage of apoptotic neurons was detected by Tunel staining; immunofluorescent double-labeling was used to detect the expressions of caspase-3 and neuronal nuclear antigen (NeuN) in neurons; immunohistochemical staining was used to detect the microglia marker ionized calcium binding adaptor molecule-1 (IBa-1) expression; ELISA was used to detect the expressions of inflammatory factors (tumor necrosis factor [TNF]-α, interleukin [IL]-1β, IL-6, interferon [IFN]-γ) and free radicals (oxygen free radicals [ROS], nitrogen free radicals [RNS]) in the brain tissues; and immunofluorescent staining and Western blotting were used to detect the expressions of nuclear factor (NF)-κB/inducible nitric oxide synthase (iNOS). Results:(1) One, 3 and 7 d after modeling, the Garcia scores showed significant differences among the three groups ( P<0.05); as compared with the TBI group, the TBI+IFX group had significantly increased Garcia scores 3 and 7 d after modeling ( P<0.05). (2) Three d after modeling, as compared with those in the TBI group, Evans blue leakage ([18.45±1.32] μg/g vs. [16.38±1.25] μg/g), brain water content ([81.56±0.96]% vs. [79.97±0.79]%), percentage of injured neurons ([79.50±5.85]% vs. [68.81±7.47]%), and percentage of apoptotic neurons ([41.93±7.49]% vs. [30.59±8.60]%) in mice of the TBI+IFX group were significantly deceased ( P<0.05). Three d after modeling, immunofluorescent double labeling showed that the relative caspase-3 expression in the TBI+IFX group (0.76±0.16) was significantly decreased as compared with the TBI group (1.11±0.23, P<0.05). Immunohistochemical staining and ELISA results showed that as compared with those in the TBI group, the Iba-1 staining scores, TNF-α, IL-1β, IL6 and IFN-γ levels, and ROS and RNS contents in TBI+IFX group were significantly decreased ( P<0.05). Immunofluorescent staining and Western blotting showed that as compared with the TBI group, the TBI+IFX group had significantly decreased expressions of NF-κB p65, iNOS and phosphorylated nuclear factor-κB inhibitor-α, and statistically inhibited nuclear translocation of NF-κB ( P<0.05). Conclusion:IFX can reduce inflammatory response and oxidative stress response, and play a neuroprotective role, which is related to its inhibition of downstream NF-κB/iNOS pathway activation.

Expression of brain-derived neurotrophic factor at acute inflammatory injury of the brain

Regulation of Brain-Derived Neurotrophic Factor (BDNF) Expression Following Antibiotic Treatment of Experimental Bacterial Meningitis.

Cell Apoptosis and the Expression of Bcl-2 and Bax Genes in Neurons after Traumatic Brain Injury in Rats

Brain-derived Neurotrophic Factor Combined with Neural Stem Cells Transplantation in Treatment of Severe Traumatic Brain Injury in Rats

Effects of Brain-Derived Neurotrophic Factor on Local Inflammation in Experimental Stroke of Rat

Intranasal Brain-Derived Neurotrophic Factor Protects Brain from Ischemic Insult Via Modulating Local Inflammation in Rats

Selective Loss of Brain-Derived Neurotrophic Factor Exacerbates Brain Injury by Enhancing Neuroinflammation in Experimental <i>Streptococcus pneumoniae</i> Meningitis

A study on expression of nuclear factor-kappa B、tumor necrosis factor-alpha and interleukin-6 in inflammatory response following experimental traumatic brain injury in rats.

Expression of the NLRP3 Inflammasome in Cerebral Cortex after Traumatic Brain Injury in a Rat Model

Local Injection of Lenti-BDNF at the Lesion Site Promotes M2 Macrophage Polarization and Inhibits Inflammatory Response After Spinal Cord Injury in Mice

The Expression and Its Significance of Brain-Derived Neurotrophic Factor in Different Hippocampal Subfields after Focal Cerebral Ischemia in Rats

Immune Cells Promote BDNF Expression by Infiltrated Macrophages via Interleukin 4 in the Cerebral Ischemia of Male Rats

Experimental study of NGF and BDNF Gene expression in acute peripheral nerve injury

The Expression of Nuclear Factor-Κb and Tumor Necrosis Factor-Α Following Brain Injury in Rats

Expression of myeloid differentiation primary response protein 88 (Myd88) in the cerebral cortex after experimental traumatic brain injury in rats.

Experimental study on expression changes of MCP-1 and BDNF after acute spinal cord injury in rats

Influence of Progressive Compression on the Expression of BDNF and TrkB in Chronic Spinal Cord Injury of Rats

Intranasal delivery of nerve growth factor attenuates neuroinflammation following traumatic brain injury in rats

Exogenous BDNF Increases Neurogenesis in the Hippocampus in Experimental Streptococcus Pneumoniae Meningitis.

Protective effect of infliximab on neurological function and its related mechanism in mice after traumatic brain injury

Effect of Naoyi-an on the expression of brain-derived neurotrophic factor mRNA in rats with intracerebral hemorrhage